42
6
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T10409 | ATX inhibitor 5 | PDE | |
ATX inhibitor 5 is a potent and orally active autotaxin (ATX) inhibitor (IC50 : 15.3 nM) that reduces the level of CCl4-induced hepatic fibrosis and has anti-hepatic fibrosis effects,. | |||
T10410 | ATX inhibitor 1 | PDE | |
ATX inhibitor 1 is a potent ATX inhibitor (IC50: 1.23 nM, FS-3 and 2.18 nM, bis-pNPP). | |||
T39190 | ATX-002 | ||
ATX-002 is a property-tunable lipid for RNA drug delivery. | |||
T39136 | ATX inhibitor 7 | ||
ATX inhibitor 7 is a autotaxin inhibitor and shows good oral exposure. | |||
T80039 | ATX-II | Sodium Channel | |
ATX-II, an Na+ channel modulator toxin derived from the sea anemone (Anemonia sulcata), causes delayed inactivation of the Na+ channels and has been linked to pulmonary vein arrhythmogenesis and atrial fibrillation [1] [... | |||
T61612 | ATX inhibitor 15 | ||
ATX inhibitor 15 (compound 30) is an indole-based carbamate derivative with a strong inhibitory effect on autotaxin (ATX), demonstrated by an IC50 of 2.17 nM. Additionally, ATX inhibitor 15 effectively inhibits ATX activ... | |||
T64141 | ATX inhibitor 11 | ||
ATX inhibitor 11 is a potent inhibitor of ATX (autotaxin) (IC50: 2.7 nM). ATX inhibitor 11 alleviates the severity of fibrotic tissue and effectively reduces the deposition of α-SMA, a biomarker of fibrosis, in a mouse m... | |||
T63325 | ATX inhibitor 9 | ||
ATX inhibitor 9 is a thickened heteroaryl derivative compound and a potent inhibitor of ATX. Among them Autotaxin (ATX), also known as ENPP2, is a secreted enzyme highly expressed mainly in lung cancer cells, bronchial e... | |||
T82936 | ATX-II TFA | Sodium Channel | |
ATX-II TFA, a specific Na+ channel modulator toxin, is derived from the venom of the sea anemone (Anemonia sulcata). This compound impedes the inactivation of Na+ channels and has been associated with arrhythmogenesis in... | |||
T63904 | ATX inhibitor 19 | ||
ATX inhibitor 19 is a potent inhibitor of ATX (IC50: 156 nM). | |||
T72681 | ATX inhibitor 17 | ||
ATX inhibitor 17, a powerful ATX inhibitor, exhibits an IC50 value of 0.019 µM, demonstrating significant anti-proliferative effects in breast cancer cells. | |||
T64210 | ATX inhibitor 13 | ||
ATX inhibitor 13 (compound 10c) is an orally active ATX inhibitor (IC50: 3.4 nM). ATX inhibitor 13 is capable of blocking the cell cycle of RAW264.7 cells in the G2 phase, inhibiting cell proliferation and migration and ... | |||
T63584 | ATX inhibitor 12 | ||
ATX inhibitor 12 is an orally active ATX inhibitor (IC50: 1.72 nM). In C57Bl/6J mice, oral administration of ATX inhibitor 12 at a dose of 60 mg/kg was effective in inhibiting structural lung damage and reducing fibrotic... | |||
T63845 | ATX inhibitor 14 | ||
ATX inhibitor 14, an indole-based carbamate derivative, is a potent inhibitor (IC50: 0.41 nM) of self-adhesive proteins (ATX) and has shown potential for research in fibrosis-related diseases. | |||
T63510 | ATX inhibitor 21 | ||
ATX inhibitor 21 is a potent inhibitor of ATX (IC50: 3490 nM). | |||
T63829 | ATX inhibitor 20 | ||
ATX inhibitor 20 is a potent inhibitor of ATX (IC50: 2.3 nM). | |||
T63524 | ATX inhibitor 10 | ||
ATX inhibitor 10 is a nitrogen-containing heterocyclic compound that is a potent inhibitor of ATX. Among other things, ATX plays a role in causing pathologies including fibrosis, neurodegeneration, arthritis, neuropathic... | |||
T63612 | ATX inhibitor 8 | ||
ATX inhibitor 8 is an inhibitor of the autocrine motor factor Autotaxin (ATX). | |||
T64130 | ATX inhibitor 16 | ||
ATX inhibitor 16 is a potent inhibitor of ATX (IC50: 0.0021 μM). ATX inhibitor 16 exhibits a significant anti-proliferative effect on breast cancer cells. | |||
T63564 | ATX inhibitor 22 | ||
ATX inhibitor 22 is a novel inhibitor of ATX (autotaxin) (IC50: 218.9 μM) that lacks inhibitory activity against LPAR1. | |||
T27324 | FK614 | FK 614,ATx-08-001,ATx-08001,FK-614 | |
FK-614 is a selective agonist of peroxisome proliferator-activated receptor gamma. FK-614 improves peripheral glucose utilization while decreases hepatic insulin extraction in alloxan-induced diabetic dogs. | |||
T31101 | CRT0273750 | CRT 0273750,CRT-0273750 | PDE |
CRT0273750 regulates plasma LPA levels and is suitable for in vivo studies. CRT0273750 is an autotaxin (ATX) inhibitor with IC50 of 0.014 μM. | |||
T11533 | Z-HA155 | CS-963 | PDE |
Z-HA155 (CS-963) selectively and potently inhibits autotaxin with an IC50 of 5.7 nM. | |||
TP2027 | GaTx2 | ||
Very high affinity ClC-2 blocker (apparent KD ~ 50 pM). Slows ClC-2 activation and inhibits slow-gating but does not inhibit open ClC-2 channels. Selective for ClC-2 over other ClC family members (ClC-0, ClC-1, ClC-3 and... | |||
T38759 | ONO-8430506 | PDE | |
ONO-8430506 is an orally available, potent autotaxin (ATX)/ENPP2 inhibitor (IC90: 100 nM) that inhibits ATX activity in mouse plasma. | |||
T2646 | HA130 | PDE | |
HA130 is a selective ATX (autotaxin) inhibitor. | |||
T22086 | HA 155 | Autotaxin Inhibitor IV | PDE |
HA 155 (Autotaxin Inhibitor IV) is a boronic acid-based compound, inhibiting ATX with IC50 of 5.7 nM by selectively binding to its catalytic threonine. | |||
T10545 | BIO-32546 | PDE | |
BIO-32546 (S-isomer) is a highly potent regulator of autotaxin (ATX) with an IC50 value of 1 nM. | |||
T4041 | Ziritaxestat | GLPG1690 | PDE |
Ziritaxestat (GLPG1690), an autotaxin inhibitor, currently being evaluated in an exploratory phase 2 study in idiopathic pulmonary fibrosis patients. | |||
T10415 | Autotaxin-IN-3 | PDE | |
Autotaxin-IN-3 is an inhibitor of Autotaxin (IC50 = 2.4 nM) which is responsible for the increase in lysophosphatidic acid in ascites and plasma. | |||
T3631 | PF-8380 | PDE | |
PF-8380 is an effective and orally available autotaxin inhibitor (IC50: 2.8 nM, in isolated enzyme assay; 101 nM, in the human whole blood). It modulates lysophosphatidic acid (LPA) levels in vivo/vitro by directly inhib... | |||
T14560 | BI-2545 | Others | |
BI-2545 is an autotaxin (ATX) inhibitor that significantly reduces LPA. For human ATX and rat ATX, the IC50s values are 2.2 nM and 3.4 nM , respectively. | |||
T72837 | Autotaxin-IN-6 | ||
Autotaxin-IN-6 (compound 23) is a potent inhibitor of autotaxin (ATX), exhibiting an IC50 of 30 nM, and is capable of attenuating cell migration with potential applications in anticancer research [1]. | |||
T27433 | GRI918013 | GRI 918013,GRI-918013 | |
GRI918013 is an ATX inhibitor. | |||
T70275 | PAT-347 | ||
PAT-347 is a potent Autotaxin Inhibitor. Autotaxin (ATX) is a secreted enzyme responsible for the hydrolysis of lysophosphatidylcholine (LPC) to the bioactive lysophosphatidic acid (LPA) and choline. The ATX-LPA signali... | |||
T28300 | PAT-347 sodium | PAT-347,PAT347,PAT 347 | |
PAT-347 is a potent inhibitor of Autotaxin (ATX), a secreted enzyme responsible for the hydrolysis of lysophosphatidylcholine (LPC) to the bioactive lysophosphatidic acid (LPA) and choline. | |||
T81804 | MEY-003 | ||
MEY-003, an Autotaxin (ATX) inhibitor, exhibits EC50 values of 460 nM for hATX-β and 1.09 μM for hATX-ɣ (analysis with LPC18:1), demonstrating its potency against these isoforms. It acts non-competitively with a K i of 4... | |||
T69652 | Relutrigine | PRAX-562 | |
Relutrigine (PRAX-562), an orally active persistent sodium channel inhibitor, potently and selectively targets persistent I Na, induced either by ATX-II (Nav 1.5 activator) or SCN8A mutation N1768D, with IC 50 values of ... | |||
T14352 | Autotaxin-IN-1 | PDE | |
Autotaxin-IN-1 is a potent autotaxin inhibitor, which has favorable potency (IC50=2.2 nM), PK properties, and a robust PK/PD relationship and it is used in treatment of osteoarthritis pain[1]. | |||
T38488 | S32826 | ||
S32826 is a highly potent inhibitor of autotaxin, exhibiting an IC50 value of 8.8 nM. It displays comparable inhibitory properties towards various autotaxin isoforms, including α, β, and γ. Furthermore, S32826 effectivel... | |||
T23293 | S32826 disodium | S 32826 | Others |
autotaxin inhibitor | |||
T16434 | PAT-048 | PDE | |
PAT-048 is an effective and selective autotaxin inhibitor. PAT-048 reduces dermal fibrosis in vivo. PAT-048 also inhibits IL-6 mRNA expression but displays no effect on autotaxin protein and pulmonary lysophosphatidic ac... |
Cat No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-02778 | ENPP2 Protein, Human, Recombinant (His) | Human | HEK293 |
ENPP2 (Ectonucleotide pyrophosphatase/phosphodiesterase family member 2), also referred as Autotaxin, is a secreted enzyme encoded by the ENPP2 gene. This gene product stimulates the motility of tumor cells, has angiogen... | |||
TMPH-00056 | Delta-AITX-Avd1c Protein, Anemonia sulcata, Recombinant (His) | Anemonia sulcata | Yeast |
Binds specifically to voltage-gated sodium channels (Nav) (site 3), thereby delaying their inactivation. Has a strong effect on crustaceans and insects (DmNav1) and a weaker effect on mammals. This toxin is highly potent... | |||
TMPY-02055 | ENPP2 Protein, Mouse, Recombinant (His) | Mouse | HEK293 |
ENPP2 (Ectonucleotide pyrophosphatase/phosphodiesterase family member 2), also referred as Autotaxin, is a secreted enzyme encoded by the ENPP2 gene. This gene product stimulates the motility of tumor cells, has angiogen... | |||
TMPH-00409 | BoNT/A Protein, Clostridium botulinum, Recombinant (His & SUMO) | Clostridium botulinum | E. coli |
BoNT/A Protein, Clostridium botulinum, Recombinant (His & SUMO) is expressed in E. coli. | |||
TMPY-04122 | ATOX1 Protein, Human, Recombinant (His) | Human | E. coli |
ATOX1 is a cytoplasmic copper chaperone that interacts with the copper-binding domain of the membrane copper transporters ATP7A and ATP7B. ATOX1 has also been suggested to have a potential anti-oxidant activity. As the t... | |||
TMPY-00463 | ENPP2 Protein, Cynomolgus, Recombinant (His) | Cynomolgus | HEK293 |
ENPP2 (Ectonucleotide pyrophosphatase/phosphodiesterase family member 2), also referred as Autotaxin, is a secreted enzyme encoded by the ENPP2 gene. This gene product stimulates the motility of tumor cells, has angiogen... |